| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |